Spots Global Cancer Trial Database for solid organ transplant
Every month we try and update this database with for solid organ transplant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Bortezomib Plus Rituximab for EBV+ PTLD | NCT01058239 | Post-transplant... Solid Organ Tra... Stem Cell Trans... Epstein Barr Vi... | bortezomib rituximab | 18 Years - | Massachusetts General Hospital | |
Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination | NCT00964210 | Cervical Cancer | Licensed quadri... | 12 Years - 26 Years | Murdoch Childrens Research Institute | |
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People | NCT04844489 | Autoimmune or A... HIV Multiple Sclero... Solid Tumors or... Solid Organ Tra... | Blood samples f... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients | NCT05164016 | Cancer Hematopoietic S... Transplant-Rela... Solid Tumor Mal... Hematologic Mal... Solid Organ Tra... Hematopoietic C... Cellular Therap... | - 24 Years | St. Jude Children's Research Hospital | ||
Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma | NCT04807777 | Advanced Cutane... | Ruxolitinib | 18 Years - | Columbia University | |
Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies | NCT05148806 | Solid Organ Tra... Autoimmune Dise... Haematological ... | self-administer... | 12 Years - | Imperial College London | |
HHV8 and Solid Organ Transplantation | NCT05081141 | HHV8 HHV8 Infection HHV8-Related Ma... Kaposi Sarcoma Lung Transplant... Liver Transplan... Kidney Transpla... Castleman Disea... | Diagnostic test... | 18 Years - | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People | NCT04844489 | Autoimmune or A... HIV Multiple Sclero... Solid Tumors or... Solid Organ Tra... | Blood samples f... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients | NCT05164016 | Cancer Hematopoietic S... Transplant-Rela... Solid Tumor Mal... Hematologic Mal... Solid Organ Tra... Hematopoietic C... Cellular Therap... | - 24 Years | St. Jude Children's Research Hospital | ||
DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients | NCT03110159 | Skin Cancer Non-melanoma Sk... Sun Damaged Ski... Actinic Keratos... | Levulan® Kerast... BLU-U Blue Ligh... | 18 Years - | Medical Dermatology Specialists | |
Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies | NCT05148806 | Solid Organ Tra... Autoimmune Dise... Haematological ... | self-administer... | 12 Years - | Imperial College London |